This study is currently not recruiting participants.

A Phase 2 Randomized Vehicle-Controlled Double-Blind Multicenter Study to Evaluate the Safety and Efficacy of Three Once-Daily CLS001 Topical Gels Versus Vehicle Administered for 12 weeks to Subjects with Papulopustular Rosacea

Not Recruiting
18 years - 100 years
All
Phase N/A

Brief description of study.

To evaluate the safety and efficacy of once daily application of three doses of omiganan topical gel compared to vehicle topical gel in subjects with papulopustular rosacea

Detailed description of study

To evaluate the safety and efficacy of once daily application of three doses of omiganan topical gel compared to vehicle topical gel in subjects with papulopustular rosacea

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Papulopustular Rosacea
  • Age: 18 years - 100 years
  • Gender: All
Updated on 22 Oct 2013. Study ID: CLS001-CO-PR-001.00

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team